| 2014 | 2015 | 2016 | 2018 | 2019 (projected) | Stryker Cost of Revenue | 3,319,000,000 | 3,344,000,000 | 3,830,000,000 | 3,447,000,000 | 2,750,015,789 | Stryker Consolidated Income | 515,000,000 | 1,439,000,000 | 1,647,000,000 | 1,482,300,000 | 1,167,594,737 |
Stryker is -0.5459 percent down even though market growth
 | By Vlad Skutelnik | Macroaxis Story |
This report is for traders who are contemplating to exit Stryker. I will concentrate on why it could still be a good year for Stryker traders. The company Piotroski F Score is 5 - Healthy. Considering 30-days investment horizon, Stryker is expected to generate 1.38 times more return on investment than the market. However, the company is 1.38 times more volatile than its market benchmark. It trades about 0.27 of its potential returns per unit of risk. The market is currently generating roughly 0.33 per unit of risk. We found thirty-eight available drivers for Stryker Corporation which can be compared to its competition. To make sure the equity is not overpriced, please validate all Stryker fundamentals including its Current Ratio, and the relationship between EBITDA and Number of Employees . Given that Stryker has Price to Earning of 20.08X, we advise you double-check Stryker Corporation current market performance to make sure the company can sustain itself down the road. Use Stryker to protect your portfolios against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Stryker to be traded at $183.89 in 30 days.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Raphi Shpitalnik
STRYKER CP has roughly 3.7B in cash with 1.79B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.93. This firm dividends can provide a clue to current valuation of the stock. Stryker one year expected dividend income is about $0.89 per share. About 76.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.18. Stryker recorded earning per share (EPS) of 9.34. The entity last dividend was issued on 2019-03-28. The firm had 2:1 split on 2004-05-17.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Stryker. Your research has to be compared to or analyzed against Stryker's peers to derive any actionable benefits. When done correctly, Stryker's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Stryker.
Investing in Stryker, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Stryker along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stryker's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
How important is Stryker's Liquidity
Stryker financial leverage refers to using borrowed capital as a funding source to finance Stryker ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Stryker financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Stryker's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Stryker's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Stryker's total debt and its cash.
Stryker Correlation with Peers
Investors in Stryker can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Stryker. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Stryker and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Stryker is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of Stryker for more details
Details
The latest price spikes of Stryker has created some momentum for investors as it was traded today as low as 186.11 and as high as 188.09 per share. The company executives were quite successful positioning the company components to exploit market volatility in March 2019. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 2.0659. The current volatility is consistent with the ongoing market swings in January 2019 as well as with Stryker unsystematic, company specific events. Stryker maintains profit margin of 26.12% . Stryker is trading at 187.64 which is 0.55 percent decrease. Day Low was 186.11. Stryker Return on Average Equity is increasing over the last 5 years. Also, Stryker Net Cash Flow from Investing is decreasing over the last 5 years.
To conclude, our immediate buy or sell advice on the organization is Hold. Stryker is currently overvalued with very small chance of financial distress for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Stryker. Please refer to our Terms of Use for any information regarding our disclosure principles.